A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database
Aims: To characterise prescribing patterns of antidepressants (ATDs) to children and adolescents aged ⩽18 years in the UK. Methods: Subjects issued at least one ATD prescription between 1 January 1992 and 31 December 2001 were identified from the UK General Practice Research Database. Prescribing pa...
Saved in:
Published in | Archives of disease in childhood Vol. 89; no. 12; pp. 1098 - 1102 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
London
BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health
01.12.2004
BMJ BMJ Publishing Group Ltd BMJ Publishing Group LTD |
Subjects | |
Online Access | Get full text |
ISSN | 0003-9888 1468-2044 1468-2044 |
DOI | 10.1136/adc.2004.064956 |
Cover
Loading…
Abstract | Aims: To characterise prescribing patterns of antidepressants (ATDs) to children and adolescents aged ⩽18 years in the UK. Methods: Subjects issued at least one ATD prescription between 1 January 1992 and 31 December 2001 were identified from the UK General Practice Research Database. Prescribing patterns, annual prevalence, morbidity patterns, and time to discontinuation of ATD use were identified. Results: A total of 24 976 subjects received 93 091 prescriptions; 51 868 (55.7%), 38 429 (41.3%), and 2708 (2.9%) prescriptions were for tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), and other ATDs respectively. ATD prevalence increased 1.7-fold from 1992 to 2001. TCA prevalence decreased by 30% from 3.6 to 2.5 per 1,000; SSRI prevalence increased 10 times from 0.5 to 4.6 per 1,000. In new ATD users aged ⩽10 years, the most common diagnosis associated with TCA use was nocturnal enuresis (75.1%); in those aged ⩾15 years, it was depression (45.8%). Depression was also associated with SSRI use (69.0%). For new users with depression, the median treatment durations for TCAs and SSRIs were 30 and 58 days respectively. TCA users were more likely to terminate treatment than SSRI users (TCAs v fluoxetine: 1.40, 95% CI 1.32 to 1.47; non-fluoxetine SSRIs v fluoxetine: 1.01, 95% CI 0.96 to 1.07). Conclusions: SSRIs have gained popularity for the treatment of depression compared with TCAs. TCAs are still used despite their lack of efficacy in prepubertal depression and their moderate effect in adolescents. However, >50% of subjects discontinue treatment after two months, with TCA users stopping earlier than SSRI users. |
---|---|
AbstractList | Aims: To characterise prescribing patterns of antidepressants (ATDs) to children and adolescents aged [= or <, slanted]18 years in the UK. Methods: Subjects issued at least one ATD prescription between 1 January 1992 and 31 December 2001 were identified from the UK General Practice Research Database. Prescribing patterns, annual prevalence, morbidity patterns, and time to discontinuation of ATD use were identified. Results: A total of 24 976 subjects received 93 091 prescriptions; 51 868 (55.7%), 38 429 (41.3%), and 2708 (2.9%) prescriptions were for tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), and other ATDs respectively. ATD prevalence increased 1.7-fold from 1992 to 2001. TCA prevalence decreased by 30% from 3.6 to 2.5 per 1,000; SSRI prevalence increased 10 times from 0.5 to 4.6 per 1,000. In new ATD users aged [= or <, slanted]10 years, the most common diagnosis associated with TCA use was nocturnal enuresis (75.1%); in those aged [= or >, slanted]15 years, it was depression (45.8%). Depression was also associated with SSRI use (69.0%). For new users with depression, the median treatment durations for TCAs and SSRIs were 30 and 58 days respectively. TCA users were more likely to terminate treatment than SSRI users (TCAs v fluoxetine: 1.40, 95% CI 1.32 to 1.47; non-fluoxetine SSRIs v fluoxetine: 1.01, 95% CI 0.96 to 1.07). Conclusions: SSRIs have gained popularity for the treatment of depression compared with TCAs. TCAs are still used despite their lack of efficacy in prepubertal depression and their moderate effect in adolescents. However, >50% of subjects discontinue treatment after two months, with TCA users stopping earlier than SSRI users. Aims: To characterise prescribing patterns of antidepressants (ATDs) to children and adolescents aged ⩽18 years in the UK. Methods: Subjects issued at least one ATD prescription between 1 January 1992 and 31 December 2001 were identified from the UK General Practice Research Database. Prescribing patterns, annual prevalence, morbidity patterns, and time to discontinuation of ATD use were identified. Results: A total of 24 976 subjects received 93 091 prescriptions; 51 868 (55.7%), 38 429 (41.3%), and 2708 (2.9%) prescriptions were for tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), and other ATDs respectively. ATD prevalence increased 1.7-fold from 1992 to 2001. TCA prevalence decreased by 30% from 3.6 to 2.5 per 1,000; SSRI prevalence increased 10 times from 0.5 to 4.6 per 1,000. In new ATD users aged ⩽10 years, the most common diagnosis associated with TCA use was nocturnal enuresis (75.1%); in those aged ⩾15 years, it was depression (45.8%). Depression was also associated with SSRI use (69.0%). For new users with depression, the median treatment durations for TCAs and SSRIs were 30 and 58 days respectively. TCA users were more likely to terminate treatment than SSRI users (TCAs v fluoxetine: 1.40, 95% CI 1.32 to 1.47; non-fluoxetine SSRIs v fluoxetine: 1.01, 95% CI 0.96 to 1.07). Conclusions: SSRIs have gained popularity for the treatment of depression compared with TCAs. TCAs are still used despite their lack of efficacy in prepubertal depression and their moderate effect in adolescents. However, >50% of subjects discontinue treatment after two months, with TCA users stopping earlier than SSRI users. To characterise prescribing patterns of antidepressants (ATDs) to children and adolescents aged < or =18 years in the UK. Subjects issued at least one ATD prescription between 1 January 1992 and 31 December 2001 were identified from the UK General Practice Research Database. Prescribing patterns, annual prevalence, morbidity patterns, and time to discontinuation of ATD use were identified. A total of 24,976 subjects received 93,091 prescriptions; 51,868 (55.7%), 38,429 (41.3%), and 2708 (2.9%) prescriptions were for tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), and other ATDs respectively. ATD prevalence increased 1.7-fold from 1992 to 2001. TCA prevalence decreased by 30% from 3.6 to 2.5 per 1,000; SSRI prevalence increased 10 times from 0.5 to 4.6 per 1,000. In new ATD users aged < or =10 years, the most common diagnosis associated with TCA use was nocturnal enuresis (75.1%); in those aged > or =15 years, it was depression (45.8%). Depression was also associated with SSRI use (69.0%). For new users with depression, the median treatment durations for TCAs and SSRIs were 30 and 58 days respectively. TCA users were more likely to terminate treatment than SSRI users (TCAs v fluoxetine: 1.40, 95% CI 1.32 to 1.47; non-fluoxetine SSRIs v fluoxetine: 1.01, 95% CI 0.96 to 1.07). SSRIs have gained popularity for the treatment of depression compared with TCAs. TCAs are still used despite their lack of efficacy in prepubertal depression and their moderate effect in adolescents. However, >50% of subjects discontinue treatment after two months, with TCA users stopping earlier than SSRI users. To characterise prescribing patterns of antidepressants (ATDs) to children and adolescents aged < or =18 years in the UK.AIMSTo characterise prescribing patterns of antidepressants (ATDs) to children and adolescents aged < or =18 years in the UK.Subjects issued at least one ATD prescription between 1 January 1992 and 31 December 2001 were identified from the UK General Practice Research Database. Prescribing patterns, annual prevalence, morbidity patterns, and time to discontinuation of ATD use were identified.METHODSSubjects issued at least one ATD prescription between 1 January 1992 and 31 December 2001 were identified from the UK General Practice Research Database. Prescribing patterns, annual prevalence, morbidity patterns, and time to discontinuation of ATD use were identified.A total of 24,976 subjects received 93,091 prescriptions; 51,868 (55.7%), 38,429 (41.3%), and 2708 (2.9%) prescriptions were for tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), and other ATDs respectively. ATD prevalence increased 1.7-fold from 1992 to 2001. TCA prevalence decreased by 30% from 3.6 to 2.5 per 1,000; SSRI prevalence increased 10 times from 0.5 to 4.6 per 1,000. In new ATD users aged < or =10 years, the most common diagnosis associated with TCA use was nocturnal enuresis (75.1%); in those aged > or =15 years, it was depression (45.8%). Depression was also associated with SSRI use (69.0%). For new users with depression, the median treatment durations for TCAs and SSRIs were 30 and 58 days respectively. TCA users were more likely to terminate treatment than SSRI users (TCAs v fluoxetine: 1.40, 95% CI 1.32 to 1.47; non-fluoxetine SSRIs v fluoxetine: 1.01, 95% CI 0.96 to 1.07).RESULTSA total of 24,976 subjects received 93,091 prescriptions; 51,868 (55.7%), 38,429 (41.3%), and 2708 (2.9%) prescriptions were for tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), and other ATDs respectively. ATD prevalence increased 1.7-fold from 1992 to 2001. TCA prevalence decreased by 30% from 3.6 to 2.5 per 1,000; SSRI prevalence increased 10 times from 0.5 to 4.6 per 1,000. In new ATD users aged < or =10 years, the most common diagnosis associated with TCA use was nocturnal enuresis (75.1%); in those aged > or =15 years, it was depression (45.8%). Depression was also associated with SSRI use (69.0%). For new users with depression, the median treatment durations for TCAs and SSRIs were 30 and 58 days respectively. TCA users were more likely to terminate treatment than SSRI users (TCAs v fluoxetine: 1.40, 95% CI 1.32 to 1.47; non-fluoxetine SSRIs v fluoxetine: 1.01, 95% CI 0.96 to 1.07).SSRIs have gained popularity for the treatment of depression compared with TCAs. TCAs are still used despite their lack of efficacy in prepubertal depression and their moderate effect in adolescents. However, >50% of subjects discontinue treatment after two months, with TCA users stopping earlier than SSRI users.CONCLUSIONSSSRIs have gained popularity for the treatment of depression compared with TCAs. TCAs are still used despite their lack of efficacy in prepubertal depression and their moderate effect in adolescents. However, >50% of subjects discontinue treatment after two months, with TCA users stopping earlier than SSRI users. Aims: To characterise prescribing patterns of antidepressants (ATDs) to children and adolescents aged ⩽18 years in the UK. Methods: Subjects issued at least one ATD prescription between 1 January 1992 and 31 December 2001 were identified from the UK General Practice Research Database. Prescribing patterns, annual prevalence, morbidity patterns, and time to discontinuation of ATD use were identified. Results: A total of 24 976 subjects received 93 091 prescriptions; 51 868 (55.7%), 38 429 (41.3%), and 2708 (2.9%) prescriptions were for tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), and other ATDs respectively. ATD prevalence increased 1.7-fold from 1992 to 2001. TCA prevalence decreased by 30% from 3.6 to 2.5 per 1,000; SSRI prevalence increased 10 times from 0.5 to 4.6 per 1,000. In new ATD users aged ⩽10 years, the most common diagnosis associated with TCA use was nocturnal enuresis (75.1%); in those aged ⩾15 years, it was depression (45.8%). Depression was also associated with SSRI use (69.0%). For new users with depression, the median treatment durations for TCAs and SSRIs were 30 and 58 days respectively. TCA users were more likely to terminate treatment than SSRI users (TCAs v fluoxetine: 1.40, 95% CI 1.32 to 1.47; non-fluoxetine SSRIs v fluoxetine: 1.01, 95% CI 0.96 to 1.07). Conclusions: SSRIs have gained popularity for the treatment of depression compared with TCAs. TCAs are still used despite their lack of efficacy in prepubertal depression and their moderate effect in adolescents. However, >50% of subjects discontinue treatment after two months, with TCA users stopping earlier than SSRI users. |
Audience | Professional Academic |
Author | de Vries, C S Wong, I C K Murray, M L |
AuthorAffiliation | Centre for Paediatric Pharmacy Research, School of Pharmacy, University of London, London WC1N 1AX, UK. macey.murray@ulsop.ac.uk |
AuthorAffiliation_xml | – name: Centre for Paediatric Pharmacy Research, School of Pharmacy, University of London, London WC1N 1AX, UK. macey.murray@ulsop.ac.uk |
Author_xml | – sequence: 1 givenname: M L surname: Murray fullname: Murray, M L organization: Director and Reader in Paediatric Pharmacy, Centre for Paediatric Pharmacy Research, School of Pharmacy, University of London and Institute of Child Health, University College London, London, UK – sequence: 2 givenname: C S surname: de Vries fullname: de Vries, C S organization: Director and Reader in Paediatric Pharmacy, Centre for Paediatric Pharmacy Research, School of Pharmacy, University of London and Institute of Child Health, University College London, London, UK – sequence: 3 givenname: I C K surname: Wong fullname: Wong, I C K organization: Director and Reader in Paediatric Pharmacy, Centre for Paediatric Pharmacy Research, School of Pharmacy, University of London and Institute of Child Health, University College London, London, UK |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16339645$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/15557040$$D View this record in MEDLINE/PubMed |
BookMark | eNqFks1v1DAQxSNURD_gzA1ZQnBA2q0d24lzQVoFWpAqivjo1XKcya4Xr73YDqL_PU53aaEHONnS_Gb83vgdFwfOOyiKpwTPCaHVqer1vMSYzXHFGl49KI4Iq8SsxIwdFEcYYzprhBCHxXGMa4xJKQR9VBwSznmNGT4q0gL1YVyiMRlrokrGOxTT2F8jPyDlkulhGyDGfI3IOKRXxvYBXK71SPXeQtQw1cZo3BKlFaBzcBCURR-D0sloQJ8gggp6hd6opDoV4XHxcFA2wpP9eVJ8PXv7pX03u7g8f98uLmYd5yLNGBl0iSnvFO4a6GsMQmGgAyaKEtzxHjgDWmHoWKlV1ZBO6UFgDYL1FYOOnhSvd3O3Y7eBfhKahcltMBsVrqVXRv5dcWYll_6HJDVp6ornAS_3A4L_PkJMcmOyX2uVAz9GWdW4EfwGfH4PXPsxuGxOElGKklBaskzNdtRSWZDGae8S_EzaWwtLkNl7eykXpKwbhjEvM__sT_23wn9_XwZe7AEVtbJDUE6beMdVlDYVm-Sd7jgdfIwBhjsEyylIMgdJTkGSuyDlDn6vQ5t0E4-8KGP_0be3aGK2dvuMCt_ysmjN5YerVtafW0Lbsys5WXy147vN-r-ifgFDyule |
CODEN | ADCHAK |
CitedBy_id | crossref_primary_10_1111_j_1365_2214_2006_00703_x crossref_primary_10_1089_cap_2009_0040 crossref_primary_10_1136_archdischild_2017_314692 crossref_primary_10_1177_0269881106075642 crossref_primary_10_3109_13651501_2011_640939 crossref_primary_10_1111_j_1365_2206_2010_00707_x crossref_primary_10_1007_s00787_013_0395_9 crossref_primary_10_1016_S0034_7450_13_70002_7 crossref_primary_10_1371_journal_pone_0033181 crossref_primary_10_1108_17465729200400021 crossref_primary_10_2165_11591120_000000000_00000 crossref_primary_10_1111_j_1600_0447_2006_00951_x crossref_primary_10_1089_cap_2014_0058 crossref_primary_10_1089_cap_2015_0263 crossref_primary_10_1016_j_jad_2016_12_047 crossref_primary_10_1007_s00228_014_1676_z crossref_primary_10_2165_00002018_200528120_00009 crossref_primary_10_1016_j_rcpeng_2018_05_003 crossref_primary_10_1111_j_1467_7717_2007_00341_x crossref_primary_10_1007_s10578_014_0454_6 crossref_primary_10_1016_j_jad_2021_03_022 crossref_primary_10_2165_11317630_000000000_00000 crossref_primary_10_1590_1414_431x20164806 crossref_primary_10_3109_08039488_2013_804118 crossref_primary_10_1542_peds_2007_2008 crossref_primary_10_1016_j_psiq_2011_10_001 crossref_primary_10_1177_1053825913481581 crossref_primary_10_1007_s00198_015_3213_z crossref_primary_10_1007_s40272_015_0139_z crossref_primary_10_1016_j_rcp_2018_05_001 crossref_primary_10_1177_0883073812450319 crossref_primary_10_1007_s00431_006_0244_7 crossref_primary_10_1017_S0033291724002861 crossref_primary_10_1111_j_1469_7610_2008_01938_x crossref_primary_10_1007_s40801_015_0049_y crossref_primary_10_1016_j_jad_2022_08_094 crossref_primary_10_1093_eurpub_ckr137 crossref_primary_10_1186_s12887_015_0436_2 crossref_primary_10_1002_pds_1396 crossref_primary_10_1016_j_jad_2024_01_163 crossref_primary_10_1192_bjp_bp_107_045245 crossref_primary_10_1007_s00787_014_0631_y crossref_primary_10_1097_YCO_0b013e328314b776 crossref_primary_10_1111_j_1365_2125_2009_03528_x crossref_primary_10_1097_YIC_0000000000000216 crossref_primary_10_1186_2050_6511_15_11 crossref_primary_10_1192_bjp_187_4_304 crossref_primary_10_1542_peds_2007_3349 crossref_primary_10_1111_j_1365_2125_2008_03347_x crossref_primary_10_18632_oncotarget_7049 crossref_primary_10_1097_WNF_0000000000000447 crossref_primary_10_1089_cap_2016_0017 crossref_primary_10_1007_s10654_009_9321_3 crossref_primary_10_1097_DBP_0000000000000058 crossref_primary_10_1089_cap_2007_0091 crossref_primary_10_1136_bmjopen_2019_031707 crossref_primary_10_1111_j_1365_2125_2005_02450_x crossref_primary_10_1007_s40501_015_0034_9 crossref_primary_10_1089_cap_2006_16_197 crossref_primary_10_1186_1753_2000_2_26 crossref_primary_10_1002_pds_1661 crossref_primary_10_1097_01_yco_0000228762_40979_8f crossref_primary_10_1017_S0033291716002099 crossref_primary_10_1002_pds_1027 crossref_primary_10_1016_j_chc_2006_05_006 crossref_primary_10_1111_j_1365_2125_2006_02780_x crossref_primary_10_1016_j_jad_2021_07_096 crossref_primary_10_1007_s00228_012_1233_6 crossref_primary_10_1017_S1092852913000576 crossref_primary_10_1177_070674370805300305 crossref_primary_10_1002_pits_20426 crossref_primary_10_1016_j_jad_2023_10_055 crossref_primary_10_1136_bmjopen_2018_028201 crossref_primary_10_1016_j_jadohealth_2005_07_012 crossref_primary_10_1016_j_euroneuro_2010_11_007 crossref_primary_10_1002_phar_1387 crossref_primary_10_1016_j_psychres_2010_06_007 crossref_primary_10_1007_s00787_014_0523_1 crossref_primary_10_1007_s11469_008_9167_z crossref_primary_10_1002_pds_1254 crossref_primary_10_1517_14656566_2012_726613 crossref_primary_10_1592_phco_31_7_623 crossref_primary_10_1111_j_1365_2214_2006_00588_x crossref_primary_10_1002_pds_3312 crossref_primary_10_1157_13087333 crossref_primary_10_1016_j_euroneuro_2007_06_001 crossref_primary_10_1177_070674371405900204 crossref_primary_10_1007_s00787_013_0445_3 crossref_primary_10_1016_j_euroneuro_2005_06_004 crossref_primary_10_1007_s00345_021_03664_y |
ClassificationCodes | E121920 |
ContentType | Journal Article |
Copyright | Copyright 2004 Archives of Disease in Childhood 2005 INIST-CNRS Copyright: 2004 Copyright 2004 Archives of Disease in Childhood |
Copyright_xml | – notice: Copyright 2004 Archives of Disease in Childhood – notice: 2005 INIST-CNRS – notice: Copyright: 2004 Copyright 2004 Archives of Disease in Childhood |
DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 0-V 3V. 7X7 7XB 88B 88E 88I 8A4 8AF 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA ALSLI AN0 AZQEC BBNVY BENPR BHPHI BTHHO CCPQU CJNVE DWQXO FYUFA GHDGH GNUQQ HCIFZ K9- K9. LK8 M0P M0R M0S M1P M2P M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEDU PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM |
DOI | 10.1136/adc.2004.064956 |
DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Social Sciences Premium Collection ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Education Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) Education Periodicals STEM Database ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Social Science Premium Collection British Nursing Database ProQuest Central Essentials Biological Science Collection ProQuest Central (subscription) Natural Science Collection BMJ Journals ProQuest One Education Collection ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Education Database Consumer Health Database ProQuest Health & Medical Collection Medical Database ProQuest Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Education ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Education ProQuest Central Student ProQuest Central Essentials ProQuest AP Science SciTech Premium Collection ProQuest Central China ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Social Science Premium Collection Education Collection ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Professional Education Biological Science Database ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Social Sciences Premium Collection ProQuest One Academic UKI Edition BMJ Journals ProQuest One Academic ProQuest One Academic (New) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Family Health (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central Basic ProQuest Education Journals ProQuest Science Journals British Nursing Index with Full Text ProQuest SciTech Collection ProQuest Medical Library ProQuest Education Journals (Alumni Edition) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest One Education MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1468-2044 |
EndPage | 1102 |
ExternalDocumentID | PMC1719765 4213205251 A127940052 15557040 16339645 10_1136_adc_2004_064956 ark_67375_NVC_7SC13CFV_2 archdischild |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | United Kingdom Europe United Kingdom--UK |
GeographicLocations_xml | – name: United Kingdom--UK |
GroupedDBID | --- ..I .55 .GJ .VT 0-V 0R~ 1CY 23M 23N 2WC 354 39C 3O- 4.4 40O 53G 5GY 5RE 5VS 6J9 7X7 7~S 88E 88I 8A4 8AF 8F7 8FE 8FH 8FI 8FJ 8GL 8R4 8R5 AAHLL AAKAS AAOJX AAQOH AAUVZ AAWJN AAWTL ABAAH ABJNI ABKDF ABMQD ABOCM ABPPZ ABTFR ABUWG ABVAJ ACGFO ACGFS ACGOD ACGTL ACHTP ACMFJ ACNCT ACOAB ACOFX ACPRK ACQSR ACTZY ADBBV ADCEG ADZCM AENEX AEUYN AFFNX AFKRA AFWFF AGQPQ AHMBA AHNKE AHQMW AIKWM AJYBZ ALIPV ALMA_UNASSIGNED_HOLDINGS ALSLI AN0 AOIJS ARALO ASPBG AVWKF AZFZN AZQEC BAWUL BBNVY BCR BENPR BES BHPHI BKNYI BLC BLJBA BNQBC BOMFT BPHCQ BTFSW BTHHO BVXVI C1A C45 CAG CCPQU CJNVE COF CS3 CXRWF DIK DWQXO E3Z EBS EJD EX3 F5P FEDTE FYUFA GICCO GNUQQ H13 HAJ HCIFZ HMCUK HVGLF HYE HZ~ IAO IEA IER IHR INH INR IOF IPC ISE ITC K9- KO8 KQ8 LK8 M0P M0R M1P M2P M7P NEJ NTWIH NXWIF O9- OHT OK1 OVD P2P PCD PHGZT PQEDU PQQKQ PROAC PSQYO Q2X R53 RHI RMJ RPM RV8 SJN TEORI TR2 UAW UHB UKHRP UYXKK V24 VM9 W2D W8F WH7 WOW X7M YOC YQY YYQ ZGI ZXP 3V. BSCLL FRP RHF AAFWJ AAYXX ACQHZ AERUA CITATION PHGZM ADXHL IQODW PJZUB PPXIY PQGLB CGR CUY CVF ECM EIF NPM PMFND 7XB 8FK K9. PKEHL PQEST PQUKI PRINS Q9U 7X8 5PM |
ID | FETCH-LOGICAL-b558t-41fc2035ba0b9ed70e8a0e3f01a310b5de54e360eb42ca691bacf80ce84d64eb3 |
IEDL.DBID | 7X7 |
ISSN | 0003-9888 1468-2044 |
IngestDate | Thu Aug 21 18:22:17 EDT 2025 Thu Jul 10 19:28:23 EDT 2025 Sat Aug 23 12:55:35 EDT 2025 Tue Jun 10 19:29:32 EDT 2025 Thu Jan 02 22:00:09 EST 2025 Mon Jul 21 09:16:56 EDT 2025 Tue Jul 01 00:55:20 EDT 2025 Thu Apr 24 23:01:13 EDT 2025 Wed Oct 30 09:40:04 EDT 2024 Thu Apr 24 23:02:05 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Keywords | Human Consumption Pediatrics Psychotropic Adolescent Database Antidepressant agent General practice Child Statistical study Public health |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b558t-41fc2035ba0b9ed70e8a0e3f01a310b5de54e360eb42ca691bacf80ce84d64eb3 |
Notes | istex:0B8E8736E59436A1C56A02A15C1F064CC50B4A79 local:0891098 ark:/67375/NVC-7SC13CFV-2 href:archdischild-89-1098.pdf Correspondence to: Mrs M L Murray Centre for Paediatric Pharmacy Research, School of Pharmacy, University of London, 29–39 Brunswick Square, London WC1N 1AX, UK; macey.murray@ulsop.ac.uk PMID:15557040 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://adc.bmj.com/content/archdischild/89/12/1098.full.pdf |
PMID | 15557040 |
PQID | 1828213324 |
PQPubID | 2041043 |
PageCount | 5 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_1719765 proquest_miscellaneous_67098565 proquest_journals_1828213324 gale_incontextcollege_GICCO_A127940052 pubmed_primary_15557040 pascalfrancis_primary_16339645 crossref_primary_10_1136_adc_2004_064956 crossref_citationtrail_10_1136_adc_2004_064956 istex_primary_ark_67375_NVC_7SC13CFV_2 bmj_primary_10_1136_adc_2004_064956 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2004-12-01 |
PublicationDateYYYYMMDD | 2004-12-01 |
PublicationDate_xml | – month: 12 year: 2004 text: 2004-12-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Archives of disease in childhood |
PublicationTitleAlternate | Arch Dis Child |
PublicationYear | 2004 |
Publisher | BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health BMJ BMJ Publishing Group Ltd BMJ Publishing Group LTD |
Publisher_xml | – name: BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health – name: BMJ – name: BMJ Publishing Group Ltd – name: BMJ Publishing Group LTD |
References | 11986427 - Pediatrics. 2002 May;109(5):721-7 14988209 - BMJ. 2004 Feb 28;328(7438):524-5 11437014 - J Am Acad Child Adolesc Psychiatry. 2001 Jul;40(7):762-72 11001236 - J Clin Psychopharmacol. 2000 Oct;20(5):523-30 8936916 - J Am Acad Child Adolesc Psychiatry. 1996 Nov;35(11):1491-501 15265848 - JAMA. 2004 Jul 21;292(3):338-43 11323729 - N Engl J Med. 2001 Apr 26;344(17):1279-85 15073072 - BMJ. 2004 Apr 10;328(7444):879-83 9055151 - J Dev Behav Pediatr. 1997 Feb;18(1):49-56 10697062 - JAMA. 2000 Feb 23;283(8):1025-30 11343498 - Arch Pediatr Adolesc Med. 2001 May;155(5):560-5 15169696 - Am J Psychiatry. 2004 Jun;161(6):1079-83 9134574 - Popul Trends. 1997 Spring;(87):36-40 12941675 - JAMA. 2003 Aug 27;290(8):1033-41 9842950 - JAMA. 1998 Nov 25;280(20):1752-6 3882682 - J Clin Psychiatry. 1985 Mar;46(3 Pt 2):53-8 12364842 - J Am Acad Child Adolesc Psychiatry. 2002 Oct;41(10):1205-15 15110490 - Lancet. 2004 Apr 24;363(9418):1341-5 |
References_xml | – reference: 15073072 - BMJ. 2004 Apr 10;328(7444):879-83 – reference: 9055151 - J Dev Behav Pediatr. 1997 Feb;18(1):49-56 – reference: 12941675 - JAMA. 2003 Aug 27;290(8):1033-41 – reference: 9134574 - Popul Trends. 1997 Spring;(87):36-40 – reference: 10697062 - JAMA. 2000 Feb 23;283(8):1025-30 – reference: 11986427 - Pediatrics. 2002 May;109(5):721-7 – reference: 11437014 - J Am Acad Child Adolesc Psychiatry. 2001 Jul;40(7):762-72 – reference: 14988209 - BMJ. 2004 Feb 28;328(7438):524-5 – reference: 11323729 - N Engl J Med. 2001 Apr 26;344(17):1279-85 – reference: 11343498 - Arch Pediatr Adolesc Med. 2001 May;155(5):560-5 – reference: 15169696 - Am J Psychiatry. 2004 Jun;161(6):1079-83 – reference: 9842950 - JAMA. 1998 Nov 25;280(20):1752-6 – reference: 15110490 - Lancet. 2004 Apr 24;363(9418):1341-5 – reference: 11001236 - J Clin Psychopharmacol. 2000 Oct;20(5):523-30 – reference: 12364842 - J Am Acad Child Adolesc Psychiatry. 2002 Oct;41(10):1205-15 – reference: 15265848 - JAMA. 2004 Jul 21;292(3):338-43 – reference: 3882682 - J Clin Psychiatry. 1985 Mar;46(3 Pt 2):53-8 – reference: 8936916 - J Am Acad Child Adolesc Psychiatry. 1996 Nov;35(11):1491-501 |
SSID | ssj0012883 |
Score | 2.1272793 |
Snippet | Aims: To characterise prescribing patterns of antidepressants (ATDs) to children and adolescents aged ⩽18 years in the UK. Methods: Subjects issued at least... To characterise prescribing patterns of antidepressants (ATDs) to children and adolescents aged < or =18 years in the UK. Subjects issued at least one ATD... Aims: To characterise prescribing patterns of antidepressants (ATDs) to children and adolescents aged [= or <, slanted]18 years in the UK. Methods: Subjects... To characterise prescribing patterns of antidepressants (ATDs) to children and adolescents aged < or =18 years in the UK.AIMSTo characterise prescribing... Aims: To characterise prescribing patterns of antidepressants (ATDs) to children and adolescents aged ⩽18 years in the UK. Methods: Subjects issued at least... |
SourceID | pubmedcentral proquest gale pubmed pascalfrancis crossref istex bmj |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1098 |
SubjectTerms | Adolescent Adolescents Age antidepressant Antidepressants Antidepressants, Tricyclic Antidepressive Agents - therapeutic use Anxiety Disorders ATD Biological and medical sciences Child Child, Preschool Childhood depression Children Depression (Psychology) Depression in children Depressive Disorder - drug therapy Dosage and administration Drug Prescriptions - statistics & numerical data Drug therapy Drug Utilization - statistics & numerical data Evaluation Family Practice - statistics & numerical data Female Gender Differences General aspects General Practice Research Database GPRD hazard ratio Health aspects Humans Infant Infant, Newborn Male MAOI Medical sciences Mental depression Mental Disorders monoamine oxidase inhibitor Obsessive compulsive disorder OCD Original Patient outcomes Population Practice Patterns, Physicians' - statistics & numerical data Practice research prescribing trends Prescriptions Psychological Patterns randomised controlled trial RCT Records (Forms) selective serotonin reuptake inhibitor Selective serotonin reuptake inhibitors Serotonin uptake inhibitors SSRI Suicides & suicide attempts Survival Analysis TCA Teenagers tricyclic antidepressant Tricyclic antidepressants United Kingdom Urinary incontinence |
Title | A drug utilisation study of antidepressants in children and adolescents using the General Practice Research Database |
URI | http://adc.bmj.com/content/89/12/1098.full https://api.istex.fr/ark:/67375/NVC-7SC13CFV-2/fulltext.pdf https://www.ncbi.nlm.nih.gov/pubmed/15557040 https://www.proquest.com/docview/1828213324 https://www.proquest.com/docview/67098565 https://pubmed.ncbi.nlm.nih.gov/PMC1719765 |
Volume | 89 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1bb9MwFLbYKiFeEHcCo1gCIV6y2YkvyRMqZdWEtDIBm_pm2YkzyrZ09CLx8zkncdoVcXn2Rdbxic859pfvI-S10qV2VrkYigcXQzzOY-cUi4UvKqG9Y1XDxHQ8Vken4uNETsKF2yLAKrszsTmoy1mBd-QHkAdnCRRUiXh3_SNG1Sh8XQ0SGjukh9RlCOnSk3XBxVFJt1PMy6HUC9Q-PFUHtmz4C8U-hOQc1at33NX3rdgUTugeWvsnQibtAqxWtXIXf8pHf4dV3ohTo3vkbkgw6aD1iPvklq8fkNvH4Qn9IVkOaDlfnVNwuMsA5aENxyydVRTMPA3YWMTH0GlNu7-9oa2kN_ifKCLmzynkjzRQV9OT8McV7eB89INdWoyTj8jp6PDr8CgO0guxkzJbxoJXRcJS6SxzuS8185llPq0Yt5APOll6KXyqmHciKazKubNFlbHCZ6JUAgr0x2S3ntX-KaEcCWQSb2UCpi4ld5muhNRMFwq5w7KIvALTm-uWXMM0RUmqDGwQSmQK025QRPa7rTFFYC9HEY3Lvw94ux7w37nf4F4bpMOoEW9TtHc2Biwy_GQGPNEoHy8T6Nh4w3pCO79AYJyWZnw2NPrLkKfD0ZmBjv0td9msQKVproSMyF7nPyYcGguzcfGIvFw3w-eObzi29rPVwiDdXgZJeESetM62mVoim5pgEdFbbrjugETi2y319FtDKM41h6xUPvv3op6TOx3LJeN7ZHc5X_kXkJEtXb_57Pqk9_5wfPK531yZ_QIWZjRl |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbargRcEM8SKK0lHuKS1klsJzkgtGy72tJ2qaCtejN24pSFki37EPCn-I3MJM5uF_E49WzHsjzj8Uz8-fsIeSrjPDZaGh-KB-PDeZz6xkjmc5sVPLaGFRUT00Ff9o75m1NxukR-Nm9hEFbZxMQqUOfDDP-Rb0EenIRQUIX81cVXH1Wj8Ha1kdCo3WLP_vgGJdv45e422PdZGHZ3jjo936kK-EaIZOLzoMhCFgmjmUltHjObaGajggUaUh0jciu4jSSzhoeZlmlgdFYkLLMJzyWH2hPGXSYtDl0gELRe7_QP383uLVC7t9HoS6G4dGRCQSS3dF4xJvJNSAJS1MteNl8-LZyG7kxooX2_I0hTj8FORS2w8acM-Hcg56WTsXuL3HQpLW3XPnibLNnyDrl24C7t75JJm-aj6RkFFz934CFasdrSYUHBsAOHxkVEDh2UtHlfDm05vcQ4RRGjf0YhY6WOLJseujdetAEQ0m090Xgy3yPHV2KW-2SlHJb2AaEBUtaEVosQljoXgUnigouYxZlEtrLEI09g6dVFTeehqjIokgoMhKKcXNUG8shmYxqVOb50lO04__sHL2Yf_Hfs52hrhQQcJSJ8svovkYIV6bxV7SCMUbBehNCx8obZgHr0GaF4sVD9k46K33eCqNM9UdBxfcFd5jOQUZRKLjyy1viPcmFqrOabyiMbs2YIMHhrpEs7nI4VEvwlkPZ7ZLV2tvnQAvnbOPNIvOCGsw5IXb7YUg4-VhTmQRxAHiwe_ntSG-R67-hgX-3v9vcekRsNxyYL1sjKZDS1jyEfnJh1twkp-XDV-_4XsCJxWg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZ2kSZeEHcCY7PERbxktRM7Th8QqlqqjbEyCTb1zdiJMwojHb0I-Gv8Os5JnHZFXJ72bMeyfM6xz4k_fx8hTxKVK2sSG0LxYEM4j9uhtQkLhcsKoZxlRcXEdDRI9k_E66EcrpGfzVsYhFU2e2K1UefjDP-RtyAPTiMoqCLRKjws4rjXf3nxNUQFKbxpbeQ0ahc5dD--Qfk2fXHQA1s_jaL-q_fd_dArDIRWynQWCl5kEYulNcy2Xa6YSw1zccG4gbTHytxJ4eKEOSuizCRtbk1WpCxzqcgTAXUojLtONlUsOcaYGi6KPY4qvo1aXxvKTE8rxOOkZfKKO1HsQTrQRuXsdfvl08q56E-HTbT0d4RrmilYrKilNv6UC_8O6bx0RvZvkOs-uaWd2htvkjVX3iJbR_76_jaZdWg-mZ9RcPZzDyOiFb8tHRcUTDzyuFzE5tBRSZuX5tCW00vcUxTR-mcUclfqabPpsX_tRRsoIe2ZmcEz-g45uRKj3CUb5bh09wnlSF4TOSMjWOpccpuqQkjFVJYgb1kakMew9PqiJvbQVUEUJxoMhPKcQtcGCsheYxqdeeZ0FPA4__sHzxcf_HfsZ2hrjVQcJTp1Vv8v0rAi3be6wyOF0vUygo6VNywGNJPPCMpTUg9Ou1q96_K42z_V0HFnxV2WM0jiuJ0IGZDtxn-037CmehleAdldNMNWg_dHpnTj-VQj1V8KBUBA7tXOthxaIpObYAFRK2646IAk5qst5ehjRWbOFYeMWD7496R2yRZEu35zMDh8SK41ZJuMb5ON2WTuHkFiOLM7VQRS8uGqQ_4XynJ0Kg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+drug+utilisation+study+of+antidepressants+in+children+and+adolescents+using+the+General+Practice+Research+Database&rft.jtitle=Archives+of+disease+in+childhood&rft.au=Murray%2C+M&rft.au=de+Vries%2C+C+S&rft.au=Wong%2C+I&rft.date=2004-12-01&rft.issn=0003-9888&rft.eissn=1468-2044&rft.volume=89&rft.issue=12&rft.spage=1098&rft.epage=1102&rft_id=info:doi/10.1136%2Fadc.2004.064956&rft_id=info%3Apmid%2F15557040&rft.externalDocID=PMC1719765 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0003-9888&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0003-9888&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0003-9888&client=summon |